CBIA BizCast: Benefits of Whole Genome Sequencing Part Two

This episode of the CBIA BizCast is the second of a two-part discussion on a key issue in Connecticut and across the country—whole genome sequencing. In this episode Paul Pescatello, CBIA senior counsel and executive director of the Connecticut Bioscience Growth Council speaks with Dr. Adam Matson and Dr. Louisa Kalsner from Connecticut Children’s. 

Matson is a neonatologist and lead researcher for genomic sequencing in the neonatal and pediatric population at the hospital. And Kalsner is the division head for genetics.

Matson and Kalsner highlight the importance of whole genome sequencing in both research and clinical settings. 

They also discuss the technology’s future and its value to patients, caregivers, and families.

Please click here for part one of our discussion on whole genome sequencing with Alexion Pharmaceuticals, Inc.’s Dr. Tom Defay. 

---

Paul Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut. Follow him on X @CTBio.

---

The CBIA BizCast is made possible through the generous support of Google. Please rate, review, and subscribe to the BizCast wherever you get your podcasts—we appreciate your support! If you have a story to tell, contact Amanda Marlow.